{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:45:18Z","timestamp":1794941118767,"version":"4.9.1"},"reference-count":30,"publisher":"Japan Atherosclerosis Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.5551\/jat.49783","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T17:04:20Z","timestamp":1582823060000},"page":"1176-1182","source":"Crossref","is-referenced-by-count":16,"title":["Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase"],"prefix":"10.5551","volume":"27","author":[{"given":"Xianda","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University"},{"name":"Department of Neurology, The Wenzhou Third Clinical Institute Affiliated To Wenzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungang","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jueyue","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zusen","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hacke W, Kaste M, Skyhoj Olsen T, Orgogozo JM, and Bogousslavsky J. European Stroke Initiative (EUSI) recommendations for stroke management. The European Stroke Initiative Writing Committee. Eur J Neurol, 2000; 7: 607-623","DOI":"10.1046\/j.1468-1331.2000.00137.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL, and American Heart Association Stroke C. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke, 2018; 49: e46-e110","DOI":"10.1161\/STR.0000000000000211"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, and Investigators E. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med, 2008; 359: 1317-1329","DOI":"10.1056\/NEJMoa0804656"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Lees K, Bluhmki E, von Kummer R, Brott T, Toni D, Grotta J, Albers G, Kaste M, Marler J, Hamilton S, Tilley B, Davis S, Donnan G, Hacke W, Allen K, Mau J, Meier D, del Zoppo G, De Silva D, Butcher K, Parsons M, Barber P, Levi C, Bladin C, and Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet, 2010; 375: 1695-1703","DOI":"10.1016\/S0140-6736(10)60491-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Derex L, and Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry, 2008; 79: 1093-1099","DOI":"10.1136\/jnnp.2007.133371"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Karaszewski B, Houlden H, Smith EE, Markus HS, Charidimou A, Levi C, and Werring DJ. What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers. J Neurol Neurosurg Psychiatry, 2015; 86: 1127-1136","DOI":"10.1136\/jnnp-2014-309705"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) National Institute of Neurological D, and Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995; 333: 1581-1587","DOI":"10.1056\/NEJM199512143332401"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Larrue V, von Kummer RR, Muller A, and Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke, 2001; 32: 438-441","DOI":"10.1161\/01.STR.32.2.438"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, Erila T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kohrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G, and Safe Implementation of Thrombolysis in Stroke MSI. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke, 2008; 39: 3316-3322","DOI":"10.1161\/STROKEAHA.107.510768"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yaghi S, Eisenberger A, and Willey JZ. Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment. JAMA neurology, 2014; 71: 1181-1185","DOI":"10.1001\/jamaneurol.2014.1210"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Strbian D, Sairanen T, Meretoja A, Pitkaniemi J, Putaala J, Salonen O, Silvennoinen H, Kaste M, and Tatlisumak T. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology, 2011; 77: 341-348","DOI":"10.1212\/WNL.0b013e3182267b8c"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Chang A, Llinas EJ, Chen K, Llinas RH, and Marsh EB. Shorter Intensive Care Unit Stays? The Majority of Post-Intravenous tPA (Tissue-Type Plasminogen Activator) Symptomatic Hemorrhages Occur Within 12 Hours of Treatment. Stroke, 2018; 49: 1521-1524","DOI":"10.1161\/STROKEAHA.118.021398"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Whiteley WN, Slot KB, Fernandes P, Sandercock P, and Wardlaw J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke, 2012; 43: 2904-2909","DOI":"10.1161\/STROKEAHA.112.665331"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, and Marler J. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke, 1994; 25: 2220","DOI":"10.1161\/01.STR.25.11.2220"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Matrat A, De Mazancourt P, Derex L, Nighoghossian N, Ffrench P, Rousson R, and Hanss M. Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke. Thromb Res, 2013; 131: e45-48","DOI":"10.1016\/j.thromres.2012.11.009"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yaghi S, Willey J, Cucchiara B, Goldstein J, Gonzales N, Khatri P, Kim L, Mayer S, Sheth K, and Schwamm L. Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke, 2017; 48: e343-e361","DOI":"10.1161\/STR.0000000000000152"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Khatri P, Wechsler LR, and Broderick JP. Intracranial hemorrhage associated with revascularization therapies. Stroke, 2007; 38: 431-440","DOI":"10.1161\/01.STR.0000254524.23708.c9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Seet RC, and Rabinstein AA. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Cerebrovasc Dis, 2012; 34: 106-114","DOI":"10.1159\/000339675"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gumbinger C, Gruschka P, Bottinger M, Heerlein K, Barrows R, Hacke W, and Ringleb P. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage. Stroke, 2012; 43: 240-242","DOI":"10.1161\/STROKEAHA.111.623033"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, and van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke, 1988; 19: 604-607","DOI":"10.1161\/01.STR.19.5.604"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Heldner MR, Mattle HP, Jung S, Fischer U, Gralla J, Zubler C, El-Koussy M, Schroth G, Arnold M, and Mono ML. Thrombolysis in patients with prior stroke within the last 3 months. Eur J Neurol, 2014; 21: 1493-1499","DOI":"10.1111\/ene.12519"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Warach S, and Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke, 2004; 35: 2659-2661","DOI":"10.1161\/01.STR.0000144051.32131.09"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, and Levine SR. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation, 2002; 105: 1679-1685","DOI":"10.1161\/01.CIR.0000012747.53592.6A"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Dharmasaroja PA, Muengtaweepongsa S, Pattaraarchachai J, and Dharmasaroja P. Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke. J Clin Neurosci, 2012; 19: 799-803","DOI":"10.1016\/j.jocn.2011.08.035"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Hart RG, and Easton JD. Hemorrhagic infarcts. Stroke, 1986; 17: 586-589","DOI":"10.1161\/01.STR.17.4.586"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Saposnik G, Gladstone D, Raptis R, Zhou L, Hart RG, Investigators of the Registry of the Canadian Stroke N, and the Stroke Outcomes Research Canada Working G. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke, 2013; 44: 99-104","DOI":"10.1161\/STROKEAHA.112.676551"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Alderazi YJ, Barot NV, Peng H, Vahidy FS, Navalkele DD, Sangha N, Misra V, and Savitz SI. Clotting factors to treat thrombolysis-related symptomatic intracranial hemorrhage in acute ischemic stroke. J Stroke Cerebrovasc Dis, 2014; 23: e207-214","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.10.009"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Mokin M, Kass-Hout T, Kass-Hout O, Zivadinov R, and Mehta B. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke. J Stroke Cerebrovasc Dis, 2012; 21: 852-859","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.05.006"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Goldstein JN, Marrero M, Masrur S, Pervez M, Barrocas AM, Abdullah A, Oleinik A, Rosand J, Smith EE, Dzik WH, and Schwamm LH. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol, 2010; 67: 965-969","DOI":"10.1001\/archneurol.2010.175"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Yaghi S, Boehme AK, Dibu J, Leon Guerrero CR, Ali S, Martin-Schild S, Sands KA, Noorian AR, Blum CA, Chaudhary S, Schwamm LH, Liebeskind DS, Marshall RS, and Willey JZ. Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective Study. JAMA neurology, 2015; 72: 1451-1457","DOI":"10.1001\/jamaneurol.2015.2371"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/11\/27_49783\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T22:50:10Z","timestamp":1604703010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/11\/27_49783\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.49783","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}